Area of research
Cancer Research · Surgery
Research interest
Research focused on Microsatellite instability and Promoter, with related work in MSH2, Renal cell carcinoma, Prostate cancer. Notable publications include 'Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment', 'Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma', and 'Frequency of <b><i>TERT</i></b> Promoter Mutations in Prostate Cancer'.
Angiomatoid fibrous histiocytoma occurring at distal/acral extremity sites: clinicopathological and molecular study of 26 cases highlighting frequent myxoid histology and site-dependent genotypic variation
Extra-abdominal and intra-abdominal FET::CREM fusion mesenchymal neoplasms: comparative clinicopathological study of 9 new cases further supporting a distinct potentially aggressive sarcoma and report of novel sites
Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment
Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy
No Evidence of Microsatellite Instability and Loss of Mismatch-Repair-Protein Expression in Squamous Cell Carcinoma of the Penis
Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma
<i>TERT</i> Core Promotor Mutations in Early-Onset Bladder Cancer
The Microphthalmia-Associated Transcription Factor p.E318K Mutation Does Not Play a Major Role in Sporadic Renal Cell Tumors from Caucasian Patients
Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients
Abstract 3700: Association of the G/G-SNP309 variant in the mdm2 gene with earlier tumor onset in female renal cell carcinoma patients
Die G/G-Variante des SNP309 im mdm2 Gen ist mit einem früheren Tumorentstehen in Nierenzellkarzinom-Patientinnen assoziiert
Frequency of <b><i>TERT</i></b> Promoter Mutations in Prostate Cancer
Low Frequency of HNPCC-Associated Microsatellite Instability and Aberrant MMR Protein Expression in Early-Onset Bladder Cancer
Frequency of activating mutations in FGFR2 exon 7 in bladder tumors from patients with early-onset and regular-onset disease.
PubMed 2014cited by 11position: last
<b><i>Mdm2</i></b> SNP309 G-Variant Is Associated with Invasive Growth of Human Urinary Bladder Cancer
Mismatch Repair Proteins hMLH1 and hMSH2 Are Differently Expressed in the Three Main Subtypes of Sporadic Renal Cell Carcinoma
NAD(P)H:Quinone Oxidoreductase 1 (NQO1) P187S Polymorphism and Prostate Cancer Risk in Caucasians
Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria
Abstract 1167: The expression of urokinase plasminogen activator (uPA) system genes in prostate carcinoma is related to clinicopathological parameters